Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]
NCT02151786
·
clinicaltrials.gov ↗
COMPLETED
Status
1120
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastric Ulcer, Duodenal Ulcer, Acute Stress Gastritis, and Acute Gastric Mucosal Lesions
Interventions
DRUG:
Lansoprazole
Sponsor
Takeda